561 related articles for article (PubMed ID: 33391541)
1. Circular RNA circDLC1 inhibits MMP1-mediated liver cancer progression via interaction with HuR.
Liu H; Lan T; Li H; Xu L; Chen X; Liao H; Chen X; Du J; Cai Y; Wang J; Li X; Huang J; Yuan K; Zeng Y
Theranostics; 2021; 11(3):1396-1411. PubMed ID: 33391541
[No Abstract] [Full Text] [Related]
2. CircBACH1 (hsa_circ_0061395) promotes hepatocellular carcinoma growth by regulating p27 repression via HuR.
Liu B; Yang G; Wang X; Liu J; Lu Z; Wang Q; Xu B; Liu Z; Li J
J Cell Physiol; 2020 Oct; 235(10):6929-6941. PubMed ID: 32003018
[TBL] [Abstract][Full Text] [Related]
3. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of hsa_circ_0074854 Suppresses the Migration and Invasion in Hepatocellular Carcinoma via Interacting with HuR and via Suppressing Exosomes-Mediated Macrophage M2 Polarization.
Wang Y; Gao R; Li J; Tang S; Li S; Tong Q; Li S
Int J Nanomedicine; 2021; 16():2803-2818. PubMed ID: 33880025
[TBL] [Abstract][Full Text] [Related]
5. CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway.
Liu YM; Cao Y; Zhao PS; Wu LY; Lu YM; Wang YL; Zhao JF; Liu XG
Int J Biol Sci; 2022; 18(2):637-651. PubMed ID: 35002514
[No Abstract] [Full Text] [Related]
6. Circular RNA expression and circPTPRM promotes proliferation and migration in hepatocellular carcinoma.
Luo Z; Mao X; Cui W
Med Oncol; 2019 Sep; 36(10):86. PubMed ID: 31494761
[TBL] [Abstract][Full Text] [Related]
7. Circular RNA circRHOT1 promotes hepatocellular carcinoma progression by initiation of NR2F6 expression.
Wang L; Long H; Zheng Q; Bo X; Xiao X; Li B
Mol Cancer; 2019 Jul; 18(1):119. PubMed ID: 31324186
[TBL] [Abstract][Full Text] [Related]
8. Circular RNA circ_KIAA1429 accelerates hepatocellular carcinoma progression via the miR-133a-3p/high mobility group AT-hook 2 (HMGA2) axis in an m6A-dependent manner.
Zhang CP; Huang XY
Hum Cell; 2023 Sep; 36(5):1741-1754. PubMed ID: 37368192
[TBL] [Abstract][Full Text] [Related]
9. KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3.
Lan T; Li H; Zhang D; Xu L; Liu H; Hao X; Yan X; Liao H; Chen X; Xie K; Li J; Liao M; Huang J; Yuan K; Zeng Y; Wu H
Mol Cancer; 2019 Dec; 18(1):186. PubMed ID: 31856849
[TBL] [Abstract][Full Text] [Related]
10. KIAA1429 regulates cell proliferation by targeting c-Jun messenger RNA directly in gastric cancer.
Miao R; Dai CC; Mei L; Xu J; Sun SW; Xing YL; Wu LS; Wang MH; Wei JF
J Cell Physiol; 2020 Oct; 235(10):7420-7432. PubMed ID: 32052427
[TBL] [Abstract][Full Text] [Related]
11. CircSETD3 (Hsa_circ_0000567) acts as a sponge for microRNA-421 inhibiting hepatocellular carcinoma growth.
Xu L; Feng X; Hao X; Wang P; Zhang Y; Zheng X; Li L; Ren S; Zhang M; Xu M
J Exp Clin Cancer Res; 2019 Feb; 38(1):98. PubMed ID: 30795787
[TBL] [Abstract][Full Text] [Related]
12. KIAA1429 facilitates metastasis via m6A-YTHDC1-dependent RND3 down-regulation in hepatocellular carcinoma cells.
Shan M; Liu D; Sun L; Yang M; He M; Zhang Y; Xiang L; Lu L; He H; Niu D; Chen L; Li S; Chen A; He F; Wang Y; Lian J
Cancer Lett; 2024 Mar; 584():216598. PubMed ID: 38224863
[TBL] [Abstract][Full Text] [Related]
13. circ_KIAA1429 accelerates hepatocellular carcinoma advancement through the mechanism of m
Wang M; Yang Y; Yang J; Yang J; Han S
Life Sci; 2020 Sep; 257():118082. PubMed ID: 32653519
[TBL] [Abstract][Full Text] [Related]
14. Circular RNA circ-102,166 acts as a sponge of miR-182 and miR-184 to suppress hepatocellular carcinoma proliferation and invasion.
Li R; Deng Y; Liang J; Hu Z; Li X; Liu H; Wang G; Fu B; Zhang T; Zhang Q; Yang Y; Chen G; Liu W
Cell Oncol (Dordr); 2021 Apr; 44(2):279-295. PubMed ID: 33034848
[TBL] [Abstract][Full Text] [Related]
15. Circ-TCF4.85 silencing inhibits cancer progression through microRNA-486-5p-targeted inhibition of ABCF2 in hepatocellular carcinoma.
Gao J; Dai C; Yu X; Yin XB; Zhou F
Mol Oncol; 2020 Feb; 14(2):447-461. PubMed ID: 31758671
[TBL] [Abstract][Full Text] [Related]
16. CircMTO1 suppresses hepatocellular carcinoma progression via the miR-541-5p/ZIC1 axis by regulating Wnt/β-catenin signaling pathway and epithelial-to-mesenchymal transition.
Li D; Zhang J; Yang J; Wang J; Zhang R; Li J; Zhang R
Cell Death Dis; 2021 Dec; 13(1):12. PubMed ID: 34930906
[TBL] [Abstract][Full Text] [Related]
17. The lncRNA
Zhou N; Li S; Wu D; Zhang F; Tang F; Li Y
DNA Cell Biol; 2021 Oct; 40(10):1278-1289. PubMed ID: 34558987
[TBL] [Abstract][Full Text] [Related]
18. Hsa_circ_0003998 promotes epithelial to mesenchymal transition of hepatocellular carcinoma by sponging miR-143-3p and PCBP1.
Song LN; Qiao GL; Yu J; Yang CM; Chen Y; Deng ZF; Song LH; Ma LJ; Yan HL
J Exp Clin Cancer Res; 2020 Jun; 39(1):114. PubMed ID: 32552766
[TBL] [Abstract][Full Text] [Related]
19. CPSF4 regulates circRNA formation and microRNA mediated gene silencing in hepatocellular carcinoma.
Wang X; Dong J; Li X; Cheng Z; Zhu Q
Oncogene; 2021 Jun; 40(25):4338-4351. PubMed ID: 34103682
[TBL] [Abstract][Full Text] [Related]
20. Activation of YAP1 by N6-Methyladenosine-Modified circCPSF6 Drives Malignancy in Hepatocellular Carcinoma.
Chen Y; Ling Z; Cai X; Xu Y; Lv Z; Man D; Ge J; Yu C; Zhang D; Zhang Y; Xie H; Zhou L; Wu J; Zheng S
Cancer Res; 2022 Feb; 82(4):599-614. PubMed ID: 34916222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
